Violich Capital Management, Inc. Novartis Ag Transaction History

Violich Capital Management, Inc.

$769 Million
Q3 2024

A detailed history of Violich Capital Management, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Violich Capital Management, Inc. holds 4,412 shares of NVS stock, worth $458,186. This represents 0.07% of its overall portfolio holdings.

Number of Shares

4,412

Previous 4,412 -0.0%

Holding current value

$458,186

Previous $470,000 7.87%

% of portfolio

0.07%

Previous 0.06%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$95.27 - $108.47 $15,433 - $17,572	162 Added 3.81%	4,412 $427,000
Q3 2022 Oct 17, 2022	SELL	$74.61 - $87.26 $29,844 - $34,904	-400 Reduced 8.6%	4,250 $323,000
Q1 2022 Apr 25, 2022	SELL	$80.11 - $90.62 $7,209 - $8,155	-90 Reduced 1.9%	4,650 $408,000
Q3 2021 Oct 12, 2021	BUY	$81.78 - $95.14 $65,424 - $76,112	800 Added 20.3%	4,740 $388,000
Q2 2021 Jul 29, 2021	SELL	$85.24 - $94.15 $68,192 - $75,320	-800 Reduced 16.88%	3,940 $359,000
Q3 2020 Oct 19, 2020	SELL	$82.14 - $91.0 $259,233 - $287,196	-3,156 Reduced 39.97%	4,740 $412,000
Q2 2020 Aug 03, 2020	BUY	$80.93 - $91.1 $12,625 - $14,211	156 Added 2.02%	7,896 $690,000
Q1 2020 Apr 30, 2020	BUY	$70.67 - $99.01 $21,201 - $29,703	300 Added 4.03%	7,740 $638,000
Q4 2018 Feb 12, 2019	BUY	$73.66 - $82.02 $18,415 - $20,505	250 Added 3.48%	7,440 $638,000
Q3 2018 Nov 08, 2018	SELL	$66.94 - $77.43 $28,114 - $32,520	-420 Reduced 5.52%	7,190 $619,000
Q2 2018 Aug 03, 2018	SELL	$64.91 - $73.36 $5,841 - $6,602	-90 Reduced 1.17%	7,610 $575,000
Q3 2017 Nov 14, 2017	SELL	$74.14 - $77.27 $7,414 - $7,727	-100 Reduced 1.28%	7,700 $661,000
Q2 2017 Aug 14, 2017	BUY	N/A	7,800	7,800 $0

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Violich Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Violich Capital Management, Inc. with notifications on news.

Account

Violich Capital Management, Inc. Novartis Ag Transaction History